Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
Volume: 42, Pages: 102185 - 102185
Published: Jul 1, 2020
Abstract
Dear Editor, We have read with great interest the case report of a patient with Multiple Sclerosis (MS) treated with ocrelizumab that developed COVID-19 without serious complications (Novi et al., 2020Novi G Mikulska M Briano F Toscanini F Tazza F Uccelli A et al.COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?.Mult. Scler. Relat. Disord. 2020;...
Paper Details
Title
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
Published Date
Jul 1, 2020
Volume
42
Pages
102185 - 102185
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History